GC Green Cross announced on May 15 that it has been selected as a key research institution for the "AI-Medicine Drug Development Full Cycle Multi-Agent AI Platform Construction and Demonstration" project, led by the Ministry of Science and ICT.
This initiative is a national project with a total government funding of approximately 17.7 billion won over 57 months. It aims to establish a system where large language model (LLM)-based specialized AI agents collaborate to carry out the entire drug development process, from target discovery to preclinical candidate selection.
GC Green Cross will be responsible for the "platform demonstration," which involves validating and optimizing the candidate substances identified by the AI platform through actual experiments. The company expects this will enhance the predictive accuracy of AI models and reduce the time required for discovering new drug candidates.
The company possesses the capability to conduct the entire drug development process, from small molecule synthesis to drug activity and efficacy evaluation, as well as non-clinical research. Its prior experience in implementing and utilizing various AI platforms was also a factor in its selection for this project.
The domestic pharmaceutical industry currently faces a shortage of professionals capable of understanding statistics and handling diverse pharmaceutical data. Since 2020, the company has operated an AI Data Center to disseminate AI big data across its research and development efforts.
The project is overseen by Yonsei University, with Aizen, Hitz, Mokam Life Science Research Institute, and the Korea Biotechnology Research Institute responsible for AI platform development, while GC Green Cross, Daewoong Pharmaceutical, and Yonsei University will handle platform validation.
Jae-wook Jeong, head of R&D at GC Green Cross, stated, "We will enhance the completeness of the AI platform based on our accumulated drug development experience and contribute to strengthening the global competitiveness of the domestic bio industry."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.